ID: ALA565957

Max Phase: Preclinical

Molecular Formula: C12H11F3O3

Molecular Weight: 260.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)C(CC(=O)C(F)(F)F)Cc1ccccc1

Standard InChI:  InChI=1S/C12H11F3O3/c13-12(14,15)10(16)7-9(11(17)18)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,17,18)

Standard InChI Key:  YFBZRNCKPGDTBO-UHFFFAOYSA-N

Associated Targets(Human)

Carboxypeptidase A1 146 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 260.21Molecular Weight (Monoisotopic): 260.0660AlogP: 2.45#Rotatable Bonds: 5
Polar Surface Area: 54.37Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.23CX Basic pKa: CX LogP: 3.18CX LogD: 0.17
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.88Np Likeness Score: -0.08

References

1. Wang SF, Tian GR, Zhang WZ, Jin JY..  (2009)  Characterization of alpha-nitromethyl ketone as a new zinc-binding group based on structural analysis of its complex with carboxypeptidase A.,  19  (17): [PMID:19646864] [10.1016/j.bmcl.2009.07.060]

Source